Verbascoside (1) is a phenylethanoid glycoside that has antileishmanial activity against Leishmania infantum and Leishmania donovani. In this study, we verified the activity of 1 on Leishmania amazonensis and arginase inhibition. Compound 1 showed an EC50 of 19 μM against L. amazonensis promastigotes and is a competitive arginase inhibitor (Ki = 0.7 μM). Docking studies were performed to assess the interaction of 1 with arginase at the molecular level. Arginase is an enzyme of the polyamine biosynthesis pathway that is important to parasite infectivity, and the results of our study suggest that 1 could be useful to develop new approaches for treating leishmaniasis
International audienceCaffeic acid and related natural compounds were previously described as Leishm...
International audienceCaffeic acid and related natural compounds were previously described as Leishm...
International audienceCaffeic acid and related natural compounds were previously described as Leishm...
Verbascoside (1) is a phenylethanoid glycoside that has antileishmanial activity against Leishmania ...
Verbascoside (1) is a phenylethanoid glycoside that has antileishmanial activity against Leishmania ...
Verbascoside (1) is a phenylethanoid glycoside that has antileishmanial activity against Leishmania ...
Verbascoside (1) is a phenylethanoid glycoside that has antileishmanial activity against Leishmania ...
Verbascoside (1) is a phenylethanoid glycoside that has antileishmanial activity against Leishmania ...
Inhibition of Leishmania arginase leads to a decrease in parasite growth and infectivity and thus re...
This study describes the activity of five natural hydroxycinnamic acids and derived compound: caffei...
This study describes the activity of five natural hydroxycinnamic acids and derived compound: caffei...
This study describes the activity of five natural hydroxycinnamic acids and derived compound: caffei...
This study describes the activity of five natural hydroxycinnamic acids and derived compound: caffei...
This study describes the activity of five natural hydroxycinnamic acids and derived compound: caffei...
Epigallocatechin-3-gallate (EGCG), a dietary polyphenol (flavanol) from green tea, possesses leishma...
International audienceCaffeic acid and related natural compounds were previously described as Leishm...
International audienceCaffeic acid and related natural compounds were previously described as Leishm...
International audienceCaffeic acid and related natural compounds were previously described as Leishm...
Verbascoside (1) is a phenylethanoid glycoside that has antileishmanial activity against Leishmania ...
Verbascoside (1) is a phenylethanoid glycoside that has antileishmanial activity against Leishmania ...
Verbascoside (1) is a phenylethanoid glycoside that has antileishmanial activity against Leishmania ...
Verbascoside (1) is a phenylethanoid glycoside that has antileishmanial activity against Leishmania ...
Verbascoside (1) is a phenylethanoid glycoside that has antileishmanial activity against Leishmania ...
Inhibition of Leishmania arginase leads to a decrease in parasite growth and infectivity and thus re...
This study describes the activity of five natural hydroxycinnamic acids and derived compound: caffei...
This study describes the activity of five natural hydroxycinnamic acids and derived compound: caffei...
This study describes the activity of five natural hydroxycinnamic acids and derived compound: caffei...
This study describes the activity of five natural hydroxycinnamic acids and derived compound: caffei...
This study describes the activity of five natural hydroxycinnamic acids and derived compound: caffei...
Epigallocatechin-3-gallate (EGCG), a dietary polyphenol (flavanol) from green tea, possesses leishma...
International audienceCaffeic acid and related natural compounds were previously described as Leishm...
International audienceCaffeic acid and related natural compounds were previously described as Leishm...
International audienceCaffeic acid and related natural compounds were previously described as Leishm...